Dr. Om Shrivastav is a Consultant in Infectious diseases and Immunology at Sir H. N. Reliance Foundation Hospital and Research Centre.
He has completed his training in M.D. (Medicine) from India. He then commenced his training in Sydney, Australia where he trained at St. Vincent’s Hospital, Liverpool Hospital & Royal North Shore Hospital.
He was the Principal Investigator, RALTEGRAVIR - newest group of drug in treatment of HIV, approved for use in 2010. Jaslok Hospital Mumbai was selected for trial and was concluded successfully after five years.
Specialties
Primary Care Physician
Condition Treated
Piles Treatment (Non Surgical)
Gestational Diabetes Management
Type 2 Diabetes Treatment
Diabetes Management
Viral Fever Treatment
Bronchial Asthma Treatment
Rheumatologic Disorders
Neuropsychiatric Disorders
Metabolic Disorders
Hematology/Oncology
Gastrointestinal Diseases
Cardiovascular Diseases
Wound Healing
Trunk
Skin
Rhytidectomy
Nose
Lower Extremity Reconstruction
Infections
Head and Neck
Hand
Flaps
Facial Fractures
Facial Augmentation
Eyelids
Craniofacial
Burns
Breast
Body Contouring
Ancillary Procedures
Upper Limb Musculoskeletal Conditions
Traumatic Brain Injury
Therapeutic Modalities
Stroke
Spinal Cord Injury
Rehabilitation Protocols
Plexopathy
Peripheral Neuropathy
Occupational Medicine
Myopathy
Muscular Dystrophy
Muscle Pain Syndromes
Movement Disorders
Medical Diseases
Lumbar Spine Disorders
Lower Limb Musculoskeletal Conditions
Disorders Of The Motor Unit
Cervical Spine Disorders
Arthritis And Connective Tissue Disorders
Jaundice Treatment
Joint and Muscle Problems
Migraine Treatment
Thyroid Disease in Children
Type 1 Diabetes Treatment
Education and Training
RESIDENCY
MD
MEDICAL SCHOOL
MBBS
Clinic Visit Time
Overview
26 years
Dr. Om Shrivastav is a Consultant in Infectious diseases and Immunology at Sir H. N. Reliance Foundation Hospital and Research Centre.
He has completed his training in M.D. (Medicine) from India. He then commenced his training in Sydney, Australia where he trained at St. Vincent’s Hospital, Liverpool Hospital & Royal North Shore Hospital.
He was the Principal Investigator, RALTEGRAVIR - newest group of drug in treatment of HIV, approved for use in 2010. Jaslok Hospital Mumbai was selected for trial and was concluded successfully after five years.
English, Hindi 